Peripheral blood stem cell transplants are safer and easier for the donor and with contemporary graft-vs-host disease (GVHD) prophylaxis, they don't appear to pose any additional GVHD risk for the ...

Relapsed/refractory peripheral and cutaneous T-cell lymphomas (R/R PTCL and CTCL) are aggressive blood cancers that often ...

Less emphasis on full HLA matching means clinicians can find an appropriate donor for any patient, says Antonio Jimenez ...

Antonio Jimenez Jimenez, MD, discusses the ACCESS trial of PTCy-based GVHD prophylaxis after mismatched unrelated donor stem ...

A new study shows that patients achieve good outcomes with a partial match drawn from the national public registry of donors when they are treated with the immune-suppressing drug cyclophosphamide.

A Little Rock church held a stem cell drive Saturday in hopes of finding a potential donor for a member with a rare type of ...

Nerve cells are not just nerve cells. Depending on how finely we distinguish, there are several hundred to several thousand ...

Posttransplant cyclophosphamide-based graft-vs-host disease (GVHD) prophylaxis enabled high 1-year overall survival in patients receiving peripheral blood stem cell (PBSC) transplants from human ...

New research suggests that specific changes in blood composition may help protect the brain and reduce the risk of developing ...

A study published in Cell Stem Cell reveals that some mutations in blood stem cells might help protect against late-onset ...